when was the first glp 1 agonist approved History of glucagon-like peptide-1 receptor agonists Timeline of GLP-1 discovery and
Description
Compared with other second- or third-line glucose-lowering medications, the GLP-1RAs demonstrated a lower rate of adverse CVEs, including heart failure (HR 0.88

Their pleiotropic benefits arise from intricate signalling cascades that regulate appetite, insulin secretion, and energy homeostasis across multiple tissues.

As the popularity of GLP-1 drugs continues to skyrocket, there has also been a huge rise in overdoses

Learn how weight loss drug coverage is changing for Medicare GLP-1 prescriptions in 2026 and how Absolute Best Insurance can help review options.

7.40.8 Eq/min/gkw)

and with patients who have taken GLP-1 drugs and experienced widely varying reactions.
